UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Disseminated inflammation of the central nervous system associated with acute hepatitis E: a case report

BMC neurology, 2020-10, Vol.20 (1), p.391-391, Article 391

2020

Link zum Volltext

Verfügbarkeit prüfen

HEV-Associated Neuralgic Amyotrophy: A Multicentric Case Series

Pathogens (Basel), 2021-05, Vol.10 (6), p.672

2021

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial on 14 versus 7 days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection

Helicobacter (Cambridge, Mass.), 2011-12, Vol.16 (6), p.420-426

2011

Link zum Volltext

Verfügbarkeit prüfen

Reproducibility of preoperative endoscopic injection of botulinum toxin into the sphincter of Oddi to prevent postoperative pancreatic fistula

Innovative surgical sciences, 2018-03, Vol.3 (1), p.69-75

2018

Link zum Volltext

Verfügbarkeit prüfen

Real-Time PCR Screening for 16S rRNA Mutations Associated with Resistance to Tetracycline in Helicobacter pylori

Antimicrobial Agents and Chemotherapy, 2005-08, Vol.49 (8), p.3166-3170

2005

Link zum Volltext

Verfügbarkeit prüfen

Effects of 16S rRNA Gene Mutations on Tetracycline Resistance in Helicobacter pylori

Antimicrobial Agents and Chemotherapy, 2003-09, Vol.47 (9), p.2984-2986

2003

Link zum Volltext

Verfügbarkeit prüfen

Anchoring fins of fully covered self-expandable metal stents affect pull-out force and stent migration

Gastrointestinal endoscopy, 2024-03, Vol.99 (3), p.377-386.e3

2024

Link zum Volltext

Verfügbarkeit prüfen

Anchoring fins of fully covered self-expanding metal stents affect pull-out force and stent migration

Gastrointestinal endoscopy, 2023-10

2023

Link zum Volltext

Verfügbarkeit prüfen

Should quinolones come first in Helicobacter pylori therapy?

Therapeutic Advances in Gastroenterology, 2011-03, Vol.4 (2), p.103-114

2011

Link zum Volltext

Verfügbarkeit prüfen

Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantation

Experimental hematology, 2022-04, Vol.108, p.36-45

2022

Link zum Volltext

Verfügbarkeit prüfen

Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial

Trials, 2023-04, Vol.24 (1), p.258-258, Article 258

2023

Link zum Volltext

Verfügbarkeit prüfen

Moderne Helicobacter-pylori-Therapien in Zeiten zunehmender Antibiotikaresistenz

Medizinische Klinik (München. 1983), 2010-11, Vol.105 (11), p.787-791

2010

Link zum Volltext

Verfügbarkeit prüfen

Modern Helicobacter pylori therapies in times of increasing anti biotic resistance

Medizinische Klinik (München. 1983), 2010-11, Vol.105 (11), p.787-791

2010

Link zum Volltext

Verfügbarkeit prüfen

Should quinolones come first in therapy?

Therapeutic advances in gastroenterology, 2011-03, Vol.4

2011

Link zum Volltext

Verfügbarkeit prüfen

M1075 Influence of Abcb1 and Cyp 2c19 Polymorphisms On Rescue Therapy of Helicobacter pylori Infection

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-344-A-344

2009

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial on 14-Days Versus 7-Days of Esomeprazole, Moxifloxacin and Amoxicillin for Second-Line or Rescue Treatment of Helicobacter pylori Infection

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-58-S-58

2011

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial on 14 versus 7 days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection: Moxifloxacin in H. pylori Therapy

Helicobacter (Cambridge, Mass.), 2011-12, Vol.16 (6), p.420-426

2011

Link zum Volltext

Verfügbarkeit prüfen

Randomized Trial on 14 versus 7days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection

Helicobacter (Cambridge, Mass.), 2011-12, Vol.16 (6), p.420-426

2011

Link zum Volltext

Verfügbarkeit prüfen

Modern Helicobacter pylori therapies in times of increasing anti biotic resistance

Medizinische Klinik (München. 1983), 2010-11, Vol.105 (11), p.787

2010

Link zum Volltext

Verfügbarkeit prüfen

979 Randomized Multicenter Study of Esomeprazole, Moxifloxacin and Amoxicillin for Second-Line or Rescue Treatment of Helicobacter pylori Infection – Impact of Treatment Duration

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-150-A-150

2009

Link zum Volltext

Verfügbarkeit prüfen

Effect of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori

Gastroenterology (New York, N.Y. 1943), 2003-04, Vol.124 (4), p.A103-A103

2003

Link zum Volltext

Verfügbarkeit prüfen

Detection of high-level tetracycline resistance in clinical isolates of Helicobacter pylori using PCR-RFLP

FEMS immunology and medical microbiology, 2004-01, Vol.40 (1), p.57-61

2004

Link zum Volltext

Verfügbarkeit prüfen

Detection of high-level tetracycline resistance in clinical isolates of Helicobacter pylori using PCR-RFLP

Pathogens and disease, 2004-01, Vol.40 (1), p.57-61

2004

Link zum Volltext

Verfügbarkeit prüfen

A transient protein folding response targets aggregation in the early phase of TDP-43-mediated neurodegeneration

Nature communications, 2024-02, Vol.15 (1), p.1508-1508

2024

Link zum Volltext

Verfügbarkeit prüfen

Beer sales in grocery and convenience stores: a glass half-full for craft brewers?

Regional studies, 2023-10, Vol.57 (10), p.1981-1994

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(17)
Humans
(15)
Helicobacter Pylori
(8)
Neurosciences & Neurology
(6)
Clinical Neurology
(5)
Male
(5)
Microbiology
(5)
Neurosciences
(5)
Adult
(4)
Aged
(4)
Female
(4)
Helicobacter Infections - Microbiology
(4)
Helicobacter Pylori - Drug Effects
(4)
Middle Aged
(4)
Biological And Medical Sciences
(3)
Gastroenterology And Hepatology
(3)
Helicobacter Pylori - Genetics
(3)
Hospitals
(3)
Levofloxacin
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Disseminated inflammation of the central nervous system associated with acute hepatitis E: a case report

HEV-Associated Neuralgic Amyotrophy: A Multicentric Case Series

Randomized Trial on 14 versus 7 days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection

Reproducibility of preoperative endoscopic injection of botulinum toxin into the sphincter of Oddi to prevent postoperative pancreatic fistula

Real-Time PCR Screening for 16S rRNA Mutations Associated with Resistance to Tetracycline in Helicobacter pylori

Effects of 16S rRNA Gene Mutations on Tetracycline Resistance in Helicobacter pylori

Anchoring fins of fully covered self-expandable metal stents affect pull-out force and stent migration

Anchoring fins of fully covered self-expanding metal stents affect pull-out force and stent migration

Should quinolones come first in Helicobacter pylori therapy?

Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantation

Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial

Moderne Helicobacter-pylori-Therapien in Zeiten zunehmender Antibiotikaresistenz

Modern Helicobacter pylori therapies in times of increasing anti biotic resistance

Should quinolones come first in therapy?

M1075 Influence of Abcb1 and Cyp 2c19 Polymorphisms On Rescue Therapy of Helicobacter pylori Infection

Randomized Trial on 14-Days Versus 7-Days of Esomeprazole, Moxifloxacin and Amoxicillin for Second-Line or Rescue Treatment of Helicobacter pylori Infection

Randomized Trial on 14 versus 7 days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection: Moxifloxacin in H. pylori Therapy

Randomized Trial on 14 versus 7days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection

Modern Helicobacter pylori therapies in times of increasing anti biotic resistance

979 Randomized Multicenter Study of Esomeprazole, Moxifloxacin and Amoxicillin for Second-Line or Rescue Treatment of Helicobacter pylori Infection – Impact of Treatment Duration

Effect of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori

Detection of high-level tetracycline resistance in clinical isolates of Helicobacter pylori using PCR-RFLP

Detection of high-level tetracycline resistance in clinical isolates of Helicobacter pylori using PCR-RFLP

A transient protein folding response targets aggregation in the early phase of TDP-43-mediated neurodegeneration

Beer sales in grocery and convenience stores: a glass half-full for craft brewers?

Suchergebnisse filtern